JP2013543862A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013543862A5 JP2013543862A5 JP2013538324A JP2013538324A JP2013543862A5 JP 2013543862 A5 JP2013543862 A5 JP 2013543862A5 JP 2013538324 A JP2013538324 A JP 2013538324A JP 2013538324 A JP2013538324 A JP 2013538324A JP 2013543862 A5 JP2013543862 A5 JP 2013543862A5
- Authority
- JP
- Japan
- Prior art keywords
- ophthalmic composition
- composition according
- agents
- pkc
- wound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41146410P | 2010-11-08 | 2010-11-08 | |
| US41146610P | 2010-11-08 | 2010-11-08 | |
| US61/411,466 | 2010-11-08 | ||
| US61/411,464 | 2010-11-08 | ||
| PCT/IL2011/000866 WO2012063237A2 (en) | 2010-11-08 | 2011-11-08 | Buffered ophthalmic compositions and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013543862A JP2013543862A (ja) | 2013-12-09 |
| JP2013543862A5 true JP2013543862A5 (cg-RX-API-DMAC7.html) | 2014-12-25 |
Family
ID=46051349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013538324A Pending JP2013543862A (ja) | 2010-11-08 | 2011-11-08 | 眼科用緩衝組成物およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20120264681A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2944319A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2013543862A (cg-RX-API-DMAC7.html) |
| CN (2) | CN104758921A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011327785A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2812164A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2013117209A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2012063237A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8455513B2 (en) | 2007-01-10 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-aminoisoquinoline compounds |
| US8450344B2 (en) | 2008-07-25 | 2013-05-28 | Aerie Pharmaceuticals, Inc. | Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| WO2010126626A2 (en) | 2009-05-01 | 2010-11-04 | Aerie Pharmaceuticals, Inc. | Dual mechanism inhibitors for the treatment of disease |
| WO2012021107A2 (en) | 2010-08-12 | 2012-02-16 | Nanyang Technological University | A liposomal formulation for ocular drug delivery |
| CN104758921A (zh) | 2010-11-08 | 2015-07-08 | 希尔洛有限公司 | 缓冲的眼用组合物以及使用其的方法 |
| US20130296250A1 (en) * | 2011-01-11 | 2013-11-07 | Healor Ltd. | Method for treatment of psoriasis |
| JP6450364B2 (ja) | 2013-03-13 | 2019-01-09 | セセン バイオ, インコーポレイテッド | 眼送達のためのキメラサイトカイン製剤 |
| ES2776199T3 (es) | 2013-03-15 | 2020-07-29 | Aerie Pharmaceuticals Inc | Conjugados de compuestos de isoquinolina y prostaglandinas |
| AU2014259948B2 (en) * | 2013-04-30 | 2019-04-18 | University Of Southern California | Accelerated healing of eye injuries by angiotensin peptides |
| US20150141328A1 (en) * | 2013-11-18 | 2015-05-21 | The Schepens Eye Research Institute | Stimulation of human meibomian gland function |
| US9956195B2 (en) | 2014-01-07 | 2018-05-01 | Nanyang Technological University | Stable liposomal formulations for ocular drug delivery |
| US9463201B2 (en) | 2014-10-19 | 2016-10-11 | M.G. Therapeutics Ltd | Compositions and methods for the treatment of meibomian gland dysfunction |
| EP3210614A4 (en) | 2014-10-22 | 2018-06-13 | G-Treebnt Co., Ltd. | Composition containing thymosin beta 4, and pharmaceutical formulation comprising same |
| EP3011959A1 (en) | 2014-10-23 | 2016-04-27 | Santen SAS | Quaternary ammonium compound for use as an inhibitor of protein kinase C alpha |
| CN104940904A (zh) * | 2015-05-27 | 2015-09-30 | 北京爱特普科技有限公司 | 一种腔体粘膜微生态调节剂及其制备方法 |
| US9867868B2 (en) * | 2015-08-18 | 2018-01-16 | G-Treebnt Co., Ltd. | Pharmaceutical composition for treating or preventing corneal wound comprising thymosin β4 and citric acid |
| KR20170021667A (ko) * | 2015-08-18 | 2017-02-28 | 주식회사 지트리비앤티 | 티모신 β4를 유효성분으로 포함하는 신경영양성각막염 치료용 조성물 |
| WO2017055924A2 (en) | 2015-09-28 | 2017-04-06 | M.G. Therapeutics Ltd. | Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion |
| WO2017178892A2 (en) | 2016-04-14 | 2017-10-19 | M.G. Therapeutics Ltd. | Selenium disulfide compositions for use in treating meibomian gland dysfunction |
| JP6943707B2 (ja) * | 2016-08-23 | 2021-10-06 | 積水化学工業株式会社 | 水溶性樹脂組成物及び水溶性樹脂フィルム |
| WO2018045091A1 (en) * | 2016-08-31 | 2018-03-08 | Aerie Pharmaceuticals, Inc. | Ophthalmic compositions |
| US10918699B2 (en) | 2017-03-22 | 2021-02-16 | Michael C. Struck | Therapeutic treatment for neurotrophic keratopathy |
| CA3057872A1 (en) | 2017-03-31 | 2018-10-04 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
| MX2020004251A (es) | 2017-10-19 | 2021-05-27 | Mona E Buice | Composición tópica para cicatrización mejorada de heridas abiertas. |
| AU2019337703B2 (en) | 2018-09-14 | 2023-02-02 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
| JP2020075918A (ja) * | 2018-11-02 | 2020-05-21 | 千寿製薬株式会社 | 角膜上皮創傷治癒促進用の眼科用組成物 |
| AU2020224106A1 (en) * | 2019-02-20 | 2021-09-09 | Eleos Pharmaceuticals, Llc | Topical composition for improved healing of ocular ailments |
| US10814001B1 (en) * | 2019-05-06 | 2020-10-27 | Rvl Pharmaceuticals, Inc. | Oxymetazoline compositions |
| EP4087655A4 (en) | 2020-01-10 | 2024-02-21 | Azura Ophthalmics Ltd | INSTRUCTIONS FOR COMPOSITION AND SENSITIVITY |
| CN111610334A (zh) * | 2020-05-18 | 2020-09-01 | 山东省肿瘤防治研究院(山东省肿瘤医院) | 一种基于细胞大小过滤识别肿瘤患者外周血循环肿瘤细胞的方法 |
| CN118340775A (zh) * | 2023-01-09 | 2024-07-16 | 维眸生物科技(浙江)有限公司 | 一种含vvn539的眼用组合物及其用途 |
| WO2025175150A1 (en) * | 2024-02-16 | 2025-08-21 | Allergan, Inc. | Enhanced artificial tear formulations |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3549747A (en) | 1968-02-20 | 1970-12-22 | Flow Pharma Inc | Contact lens wetting solution and method of using same |
| US3947573A (en) | 1969-12-01 | 1976-03-30 | Burton, Parsons And Company, Inc. | Opthalmic solution |
| US3856919A (en) | 1970-06-08 | 1974-12-24 | Burton Parsons Chemicals Inc | Ophthalmic solution |
| US3767788A (en) | 1970-06-08 | 1973-10-23 | Burton Parsons Chemicals Inc | Ophthalmic solution |
| US3767789A (en) | 1971-06-21 | 1973-10-23 | Burton Parsons & Co Inc | Method of providing a synthetic mucus in vivo |
| US3907985A (en) | 1973-07-27 | 1975-09-23 | Burton Parsons And Company Inc | Polystyrene sulfonate containing opthalmic solutions |
| US3987163A (en) | 1973-07-27 | 1976-10-19 | Burton, Parsons And Company, Inc. | Polystyrene sulfonate containing opthalmic solutions |
| US4029817A (en) | 1973-09-24 | 1977-06-14 | Allergan Pharmaceuticals | Soft contact lens preserving solutions |
| US3920810A (en) | 1974-04-23 | 1975-11-18 | Burton Parsons And Company Inc | Polyacrylamide containing ophthalmic solutions |
| US4120949A (en) | 1977-10-05 | 1978-10-17 | Cooper Laboratories, Inc. | Ophthalmic solution |
| US4131651A (en) | 1977-10-25 | 1978-12-26 | Barnes-Hind Pharmaceuticals, Inc. | Treatment of dry eye |
| US4409205A (en) | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
| IL80298A (en) | 1986-10-14 | 1993-01-31 | Res & Dev Co Ltd | Eye drops |
| US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
| CA2125060C (en) | 1993-07-02 | 1999-03-30 | Henry P. Dabrowski | Ophthalmic solution for artificial tears |
| JP3059092B2 (ja) * | 1995-11-15 | 2000-07-04 | 田辺製薬株式会社 | ドライアイおよびドライアイを原因とする疾患の予防・治療剤 |
| US20060258562A1 (en) * | 2000-07-31 | 2006-11-16 | Healor Ltd. | Methods and pharmaceutical compositions for healing wounds |
| TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
| JP4790609B2 (ja) * | 2003-07-15 | 2011-10-12 | バーイラン ユニバーシティー | 創傷治癒のための方法及び薬剤組成物 |
| ES2375565T3 (es) * | 2003-08-07 | 2012-03-02 | Healor Ltd. | Composiciones farmacéuticas y métodos para acelerar la cicatrización de heridas. |
| WO2007026356A2 (en) * | 2005-08-29 | 2007-03-08 | Healor Ltd. | Methods and compositions for prevention and treatment of diabetic and aged skin |
| ITMI20052036A1 (it) * | 2005-10-26 | 2007-04-27 | Professional Dietetics Srl | Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato |
| CA2666843C (en) * | 2006-10-20 | 2015-06-16 | Celldex Therapeutics, Inc. | Treatment of age-related macular degeneration and other diseases of the eye |
| US20080292726A1 (en) * | 2007-01-23 | 2008-11-27 | Bernstein Lawrence R | Ophthalmic gallium compositions and methods of their use |
| US20090124553A1 (en) * | 2007-05-04 | 2009-05-14 | Mochly-Rosen Daria D | Suppression of inflammation associated with transplantation using an epsilon PKC inhibitor |
| KR20100040912A (ko) * | 2007-07-30 | 2010-04-21 | 힐로 리미티드 | 약제학적 조성물 및 관련 방법 |
| US20130012447A1 (en) * | 2007-08-27 | 2013-01-10 | Eiketsu Sho | Protein kinase c-delta inhibitors that protect against cellular injury and inflammation and promote astrocyte proliferation |
| US8506944B2 (en) * | 2008-05-07 | 2013-08-13 | The Regents Of The University Of California | Replenishment and enrichment of ocular surface lubrication |
| JP5421910B2 (ja) * | 2008-06-19 | 2014-02-19 | 学校法人近畿大学 | ペプチド誘導体およびそれを含む涙液分泌促進組成物 |
| US20110223177A1 (en) * | 2008-09-09 | 2011-09-15 | University Of East Anglia | Treatment of fibrotic eye disorders |
| EP2599494A1 (en) * | 2010-01-11 | 2013-06-05 | Healor Ltd. | PKC inhibitors for the treatment of inflammatory disease or disorder |
| CN104758921A (zh) | 2010-11-08 | 2015-07-08 | 希尔洛有限公司 | 缓冲的眼用组合物以及使用其的方法 |
-
2011
- 2011-11-08 CN CN201510134566.8A patent/CN104758921A/zh active Pending
- 2011-11-08 WO PCT/IL2011/000866 patent/WO2012063237A2/en not_active Ceased
- 2011-11-08 CA CA2812164A patent/CA2812164A1/en not_active Abandoned
- 2011-11-08 JP JP2013538324A patent/JP2013543862A/ja active Pending
- 2011-11-08 CN CN2011800544664A patent/CN103249429A/zh active Pending
- 2011-11-08 EP EP15167715.0A patent/EP2944319A1/en not_active Withdrawn
- 2011-11-08 AU AU2011327785A patent/AU2011327785A1/en not_active Abandoned
- 2011-11-08 RU RU2013117209/15A patent/RU2013117209A/ru not_active Application Discontinuation
- 2011-11-08 US US13/291,553 patent/US20120264681A1/en not_active Abandoned
- 2011-11-08 EP EP11840613.1A patent/EP2637684A4/en not_active Withdrawn
-
2014
- 2014-08-14 US US14/459,376 patent/US20150094260A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4516844B2 (ja) | 創傷の処置におけるラクトフェリン | |
| US7557087B2 (en) | Compositions and methods for treating diseases | |
| RU2013117209A (ru) | Буферные глазные композиции и способы их применения | |
| ES2335437T3 (es) | Composiciones farmaceuticas oftalmicas a base de aminoacidos y de hialuronato de sodio. | |
| RU2012140704A (ru) | Способ профилактики и/или лечения фиброза и/или помутнения роговицы (варианты), способ получения фармацевтической композиции для профилактики и/или лечения фиброза и/или помутнения роговицы и глазная фармацевтическая композиция | |
| RU2008136324A (ru) | Желудочно-кишечный пролиферативный фактор и его применения | |
| US20110275688A1 (en) | Ketorolac compositions for corneal wound healing | |
| RU2010141542A (ru) | Низковязкие высокофлокулированные суспензии триамцинолона ацетонида для интравитреальных инъекций | |
| US20250000790A1 (en) | Ketorolac compositions for corneal wound healing | |
| ES2818824T3 (es) | Composiciones que comprenden una proteína de fusión de VIP-ELP para su uso en el tratamiento de fibrosis quística | |
| RU2017118405A (ru) | Новое лечение роговицы с применением ламинина | |
| RU2008140117A (ru) | МОНОМЕР TGF-β И ЕГО ПРИМЕНЕНИЕ | |
| KR101521278B1 (ko) | 펩티드 유도체 및 이를 포함하는 누액 분비 촉진 조성물 | |
| AU2023200154A1 (en) | Dosing regimens for treating hypoxia-associated tissue damage | |
| JP2005272445A (ja) | 涙液分泌促進ペプチドおよびその組成物 | |
| RU2004105844A (ru) | Новое применение 2-[5-(4-фторфенил)-3-пиридилметиламинометил]-хромана и его физиологически приемлемых солей | |
| EP4100044A1 (en) | Compositions comprising amelogenin and uses thereof | |
| CN106488773B (zh) | Apc类似物用于创伤愈合的用途 | |
| TWI758272B (zh) | 用於治療傷口之清創組合物 | |
| EA201490173A1 (ru) | Фармацевтическая композиция для лечения преждевременной эякуляции и способ лечения преждевременной эякуляции | |
| JP2011221464A (ja) | コンタクトレンズ用眼科組成物 | |
| Tchalakov et al. | Treatment of Recurrent Respiratory Papilomatosis Type II on the Larynx | |
| RU2009107917A (ru) | Аминоизохинолиновый ингибитор тромбина с улучшенной биодоступностью | |
| RU2013153733A (ru) | Композиция для лечения остеоартрита на основе модифицированной гиалуроновой кислоты или ее соли (варианты) и способ лечения остеоартрита | |
| WO2014071005A1 (en) | Methods and compositions using neuroprotective steroids and thrombolytic agents |